Diagnosis & Disease Information

Christopher Wood, MD

Drugs Will Not Replace RCC Surgery

ORLANDO—New targeted therapies for locally advanced and metastatic renal cell carcinoma (RCC) have ushered in a new era in systemic therapy, according to Christopher Wood, MD, Professor of Urology at the University of Texas M.D. Anderson Cancer Center in Houston.

CKD Knowledge Lacking, Survey Found

A 34-question knowledge survey administered to 401 adults with chronic kidney disease (CKD) provided to be a reliable and valid instrument for identifying areas of and risk factors for poor renal knowledge among these patients, but it showed that 78% of respondents did not know that the disease may progress with no symptoms.

Next post in Commentary